Lilli Podola
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
Journal: Nature medicine
Published: July 06, 2026
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 24, 2017
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.
Journal: Journal of virology
Published: May 18, 2017
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
Journal: Oncoimmunology
Published: December 02, 2016
CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo.
Journal: Journal of virology
Published: April 07, 2016
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.
Journal: Oncoimmunology
Published: October 21, 2014
Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice.
Journal: International journal of cancer
Published: August 01, 2014
Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.
Journal: PLoS neglected tropical diseases
Published: September 15, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026